Stacy S Shord

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Chronic Myeloid Leukemia

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, Sonia Hernandez-Diaz, Jamie Gutierrez, Mary Sullivan Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C Lerro, Brenda J Gehrke, Stacy S Shord, R Angelo de Claro, Marc R Theoret, Peter Joseph DeMaria, Kelly J Norsworthy
Perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nam Atiqur Rahman, Mirat Shah, Stacy S Shord
Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs. Clinical pharmacology and therapeutics (2024)
Nam Atiqur Rahman, Mirat Shah, Stacy S Shord
Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs. Clinical pharmacology and therapeutics 116 (3) (2024)
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, Sonia Hernandez-Diaz, Jamie Gutierrez, Mary Sullivan Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C Lerro, Brenda J Gehrke, Stacy S Shord, R Angelo de Claro, Marc R Theoret, Peter Joseph DeMaria, Kelly J Norsworthy
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Michael I Barbato, Jeannette Nashed, Diana Bradford, Yi Ren, Sachia Khasar, Claudia P Miller, Banu S Zolnik, Hong Zhao, Yangbing Li, Youwei Bi, Stacy S Shord, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Raniya A Al-Matari, Richard Pazdur, Paul G Kluetz, Martha Donoghue, Harpreet Singh, Nicole Drezner
FDA Approval Summary: Dabrafenib in combination with trametinib for BRAF V600E mutation-positive low-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stacy S Shord, Hao Zhu, Jiang Liu, Atiqur Rahman, Brian Booth, Issam Zineh
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer. CPT: pharmacometrics & systems pharmacology (2023)